CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 180-181
DOI: 10.4103/0971-5851.123724
ORIGINAL ARTICLE

Report of chronic myeloid leukemia from SEAROC experience, Jaipur over a period of 9 years

Anish Maru
Department of Medical Oncology, SEAROC Cancer Center, SK Soni Hospital, Jaipur, Rajasthan, India
› Author Affiliations

Abstract

SEAROC cancer center presented the data 387 patients from the city of Jaipur. This oncology center caters large number of population from Jaipur as well as from neighboring states. Out of the 387 patients, 334 (86%) patients were in chronic phase. Complete hematological response was seen in 368 (95%) of patients and no response in 5 patients. Among these patients, 33 (8.5%) progressed to blast crisis.



Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. J Natl Cancer Inst 1960;25:85.
  • 2 Lee SJ. Chronic myelogenous leukaemia. Br J Haematol 2000;111:993-1009.
  • 3 Goldman JM. How I treat chronic myeloid leukemia in the imatinib era. Blood 2007;110:2828-37.
  • 4 Marin D, Marktel S, Bua M, Armstrong L, Goldman JM, Apperley JF, et al. The use of imatinib (STI571) in chronic myelod leukemia: Some practical considerations. Haematologica 2002;87:979-88.
  • 5 Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. The effects of imatinib on pregnancy outcome. Blood 2008;111:5505-8.